BRIX BAYUGA

Brix Bayuga has over a decade of experience in regulatory affairs within the pharmaceutical industry. Brix began a career as a Regulatory Affairs Manager at Hospira, A Pfizer Company, from August 2014 to March 2016. In August 2016, Brix transitioned to Pfizer as a Senior Manager and continues to contribute to the organization. Currently, Brix serves as the Director for Global Regulatory Affairs Chemistry, Manufacturing, and Controls (GRA CMC) for Asia Pacific at Eli Lilly and Company, beginning in 2025, where leadership is provided for strategic and operational direction in CMC development and regulatory strategies across Japan, China, South Korea, and the ASEAN region. Brix holds a Bachelor of Science degree in Pharmacy from the University of Santo Tomas, attained between 2000 and 2004.